ACACA |
Q13085
|
acetyl-CoA carboxylase alpha
|
|
1.00 |
0.480 |
0.846 |
PARP1 |
P09874
|
poly(ADP-ribose) polymerase 1
|
|
3.3E-04 |
0.389 |
0.923 |
JAG1 |
P78504
|
jagged canonical Notch ligand 1
|
|
1.00 |
0.429 |
0.808 |
BIN1 |
O00499
|
bridging integrator 1
|
|
0.78 |
0.550 |
0.692 |
ANXA2 |
P07355
|
annexin A2
|
|
9.8E-05 |
0.453 |
0.808 |
ANXA7 |
P20073
|
annexin A7
|
|
8.6E-10 |
0.631 |
0.615 |
APC |
P25054
|
APC regulator of WNT signaling pathway
|
|
1.00 |
0.373 |
0.962 |
APEX1 |
P27695
|
apurinic/apyrimidinic endodeoxyribonuclease 1
|
|
1.9E-07 |
0.458 |
0.846 |
APOE |
P02649
|
apolipoprotein E
|
|
1.9E-03 |
0.338 |
0.962 |
FAS |
P25445
|
Fas cell surface death receptor
|
|
0.81 |
0.372 |
0.923 |
ARF6 |
P62330
|
ADP ribosylation factor 6
|
|
0.72 |
0.631 |
0.577 |
CEACAM1 |
P13688
|
CEA cell adhesion molecule 1
|
|
7.9E-04 |
0.525 |
0.731 |
BMI1 |
P35226
|
BMI1 proto-oncogene, polycomb ring finger
|
|
0.94 |
0.448 |
0.808 |
BSG |
P35613
|
basigin (Ok blood group)
|
|
2.6E-05 |
0.458 |
0.769 |
CCK |
P06307
|
cholecystokinin
|
|
3.3E-05 |
0.453 |
0.846 |
CD14 |
P08571
|
CD14 molecule
|
|
4.9E-05 |
0.392 |
0.885 |
CD44 |
P16070
|
CD44 molecule (Indian blood group)
|
|
2.4E-07 |
0.363 |
0.962 |
CDKN1A |
P38936
|
cyclin dependent kinase inhibitor 1A
|
|
1.9E-03 |
0.403 |
0.769 |
CDKN1B |
P46527
|
cyclin dependent kinase inhibitor 1B
|
|
0.62 |
0.409 |
0.769 |
CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
CDKN3 |
Q16667
|
cyclin dependent kinase inhibitor 3
|
|
1.9E-03 |
0.514 |
0.769 |
CEACAM5 |
P06731
|
CEA cell adhesion molecule 5
|
|
4.2E-10 |
0.420 |
0.846 |
CLU |
P10909
|
clusterin
|
|
7.8E-05 |
0.426 |
0.885 |
CREB1 |
P16220
|
cAMP responsive element binding protein 1
|
|
1.00 |
0.463 |
0.885 |
CRK |
P46108
|
CRK proto-oncogene, adaptor protein
|
|
0.96 |
0.394 |
0.923 |